6th Exosome-Based Therapeutic Development Summit
Evvnt Promotion / evvnt
17.09.2024 - 19.09.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
Temas de la conferencia
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Kimera Labs' FDA approval, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments, this summit is a must-attend event.
La Sociedad Científica
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Brochure: https://go.evvnt.com/2433871-3?pid=4832
Speakers: AJ Bergmann Chief Financial Officer Capricor Inc., Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd., Carla Mazzeo Research and Development Director Regenerelle and More.
Información e inscripción:
https://go.evvnt.com/2433871-2?pid=4832
Ms. Erin Thomas
Salud Pública, Servicios de salud
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
